Global

A report by the European Commission aimed at exploring patent exploitation by Big Pharma winds up generating more angst than answers

September 21, 2010.

Anjan Selz offers a Strengths, Weaknesses, Opportunities and Threats analysis of the biosimilars market.

September 08, 2010.

Dr Frank Floether provides a no-nonsense guide to securing a successful alliance in Asia.

August 20, 2010.

13 August, 2010.

The European Generic Medicines Association's Director for Scientific Affairs, Suzette Cox, talks to us about the environment for biosimilars.

With substantial growth predicted in the life sciences industry, appointing the right General Manager (GM) in China has never been more important. But where should he or she come from?

It's back to the future in Pharm Exec's second-annual review of industry prospects in the IMS "Pharmerging 17"

August 2, 2010.

August 01, 2010. French pharma giant accused of providing "misleading" and "incorrect" information.

July 23, 2010.

July 23, 2010.

July 14, 2010.

July 10, 2010.

Kamal Biswas outlines some techniques for the successful design and implementation of an IT shared services model in pharma.

As Europe sets the pace in slashing drug prices to meet austerity goals industry is seeking fresh ways to control the fallout. Will more dialogue be enough?

As they build market share, companies need a plan to limit exposure to steep fines and executive prosecutions.

As pharma companies protest decisions to cut drug prices in Greece, Spain and Germany, the question of fair play is brought in sharp focus. But, says Jacky Law, even-handedness in drug pricing works both ways.

June 14, 2010.

Tell us and win an iPod Touch!

June 4, 2010.

It is now the job of the pharma marketer to get people talking and to listen to what they are saying. Jody Ball offers advice on making that transition.

May 24, 2010.